NewsRx

Search our medical news database

Tuberculosis

Rifampicin Does Not Activate the Glucocorticoid Receptor

Published in TB and Outbreaks Week, May 23rd, 2000

Rifampicin, an antibiotic widely used in tuberculosis therapy, apparently does not activate the glucocorticoid receptor (GR) in human hepatocytes.

To determine whether rifampicin displayed glucocorticoid-like effects in human neuroblastoma SK-N-MC cells or mouse hippocampal HT22 cells, A.S. Herr and colleagues from the Max Planck Institute of Psychiatry, Germany, conducted a study using reporter gene assays.

Herr et al. found that the antibiotic did not elicit transactivation of GR in either cell types; however, a potent transcriptional response was caused by cortisol or dexamethasone. The same HepG2 cell line that was originally used to demonstrate...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook